• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lots of patients with cancer, cancer survivors use but don’t report complementary/alternative medicine therapies

Bioengineer by Bioengineer
April 11, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don’t disclose that to their physicians. Among about 3,100 survey participants reporting a history of cancer, 33.3 percent used CAMs in the past 12 months and the most commonly used were herbal supplements (35.8 percent), followed by other modalities that include chiropractic or osteopathic manipulation (25.4 percent); massage (14.1 percent); yoga/tai chi/qigong (7.6 percent); mantra/mindfulness/spiritual meditation (6.9 percent); special diets (2.9 percent); and acupuncture (2.0 percent). Among the 1,023 participants who reported using CAM, 288 (29.3 percent) didn’t disclose that to their physicians. Many participants said they didn’t disclose their CAM use because physicians didn’t ask or they didn’t think their physicians needed to know. Considering the high proportion of patients with cancer and cancer survivors using CAM, there needs to be more study of its use on cancer outcomes.

Authors: Nina N. Sanford, M.D., of University of Texas Southwestern, Dallas, and coauthors

(doi:10.1001/jamaoncol.2019.0349)

Editor’s Note: The article contains conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/2730130?guestAccessKey=b931cef7-147d-429b-80e7-b3d32b5182eb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041119

Media Contact
Patrick McGee

[email protected]

Tags: Alternative MedicinecancerMedicine/HealthMortality/Longevity
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Chemotherapy-Free AML: Venetoclax with Targeted, Immune Therapies

August 13, 2025
Increase in Gun Violence Depicted in Leading U.S. Films Mirrors Surge in Youth Gun Homicides

Increase in Gun Violence Depicted in Leading U.S. Films Mirrors Surge in Youth Gun Homicides

August 13, 2025

FAU Secures $700,000 EPA Grant to Enhance Water Quality Monitoring in Lake Okeechobee

August 13, 2025

Imaging Single Extracellular Vesicles with RCA-Expansion

August 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Chemotherapy-Free AML: Venetoclax with Targeted, Immune Therapies

Promising Neoadjuvant Immunochemoradiotherapy for MSS/pMMR Rectal Cancer

First Gyrodactylus perccotti Found on Chinese Sleeper

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.